Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 2, 2000, Pages 148-156

  Nopp, A ^a   Lundahl, J ^a   Hallden G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD69; Eosinophils; Flow cytometry; Monocytes; Neutrophils

Indexed keywords

CD69 ANTIGEN; EOTAXIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; LIPOPOLYSACCHARIDE;

ANTIGEN EXPRESSION; ARTICLE; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOOD PROTEINS; CELL DEGRANULATION; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; EPITOPES; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-5; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; RIBONUCLEASES; UP-REGULATION;

EID: 0033963981     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00363.x     Document Type: Article

References (42)

1. 1. WARDLAW AJ. Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J 1994;70:536-552.
2. 2. BOUSQUET J, CHANEZ P, LACOSTE J, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
3. 3. WARDLAW AJ, DUNNETTES S, GLEICH GJ, COLLINS JV, KAY AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-69.
4. 4. KAY AB, CORRIGAN CJ. Asthma: eosinophils and neutrophils. Br Med Bull 1992;48:51-64.
5. 5. FAHY JV, KIM KW, LIU J, et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbations. J Allergy Clin Immunol 1995;95:843-852.
6. 6. NOCKER RET, OUT TA, WELLER FR, MUL EPJ, JANSEN HM, VAN DER ZEE JS. Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma. Int Arch Allergy Immunol 1999;119:45-53.
7. 7. GRIFFIN E, HÅKANSSON L, FORMGREN H, JÖRGENSEN K, PETERSON C, VENGE P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991;87:548-557.
8. 8. JANSON C, HERALA M. Blood eosinophil counts as risk factor for relapse in acute asthma. Respir Med 1992;86:101-104.
9. 9. ÄDELROTH E, ROSENHALL L, JOHANSSON S, et al. Inflammatory cells and eosinophilic activity in asthma investigated by bronchoalveolar lavage. The effects of anti-asthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990; 142:91-99.
10. 10. WARDLAW A. Eosinophil density: what does it mean? Clin Exp Allergy 1995;25:1145-1149.
11. 11. HED J, HALLDÉN G. Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48 Suppl 17:87-93.
12. 12. SKEDINGER M, HALLDÉN G, LUNDAHL J, et al. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course. Ann Allergy Asthma Immunol 1995;74:250-255.
13. 13. FERNVIK E, GRÖNNEBERG R, LUNDAHL J, et al. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of mild asthmatics. Allergy 1996;51:697-705.
14. 14. KUWASAKI T, CHIHARA J, KAYABA H, et al. Whole blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma. Int Arch Allergy Immunol 1998;177 Suppl 1:77-80.
15. 15. VENGE P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 1993;25:3-7.
16. 16. VENGE P. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein. A new clinical approach to asthma management. Respir Med 1995;89:1-2.
17. 17. GLICH GJ, HAMANN KJ. Eosinophils and eosinophil granule proteins in asthma: the eosinophil hypothesis. In: KOBAYASHI S, BELLANTI JA, editors. Advances in asthmology 1990. Oxford: Elsevier, 1991:195-200.
18. 18. KARA T, JUNG LKL, BJORNDAHL JM, FU SM. Human T cell activation. III. Rapid induction of phosphorylated 28 kd/32 kd disulfide-linked early activation antigen (EA 1) by 12-0-tetradecanoyl phorbol-13-acetate, mitogens and antigens. J Exp Med 1988;164:1988-2005.
19. 19. NAKAMURA S, SUNG SJ, BJORNDAHL JM, FU SM. Human T cell activation. IV. T cell activation and proliferation via the early activation antigen. EA 1. J Exp Med 1989;169:677-688.
20. 20. TESTI R, PHILLIPS JH, LANIER LL. T cell activation via Leu-23 (CD69). J Immunol 1989;143:1123-1128.
21. bright human thymocytes. J Immunol 1988;141:2557-2563.
22. 22. RISSO A, COSULICH ME, RUBARTELLI A, MAZZA MR, BARGELLESI A. MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell percursors. Eur J Immunol 1989;19:323-328.
23. 23. LANIER LL, BUCK DW, RHODES L, et al. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 1988;167:1572-1585.
24. 24. DE MARIA R, CIFONE MG, TROTTA R, et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180:1999-2004.
25. 25. GAVIOLI R, RISSO A, SMILOVICH D, et al. CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms. Cell Immunol 1992;142:186-196.
26. 26. TESTI R, PHILLIPS JH, FRATI L, GAZZANGIA PP, SANTONI A. CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med 1990;172:701-707.
27. 27. HARTNELL A, ROBINSON DS, KAY AB, WARDLAW AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993;80:281-286.
28. 28. NISHIKAWA K, MORII T, AKO H, HAMADA K, SAITO S, NARITA N. In vivo expression on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils. J Allergy Clin Immunol 1992;90:169-174.
29. 29. BOYUM A. Separation of lymphocytes, granulocytes and monocytes from human blood using iodinated density gradient media. In: DI SABATO G, LANGONE JJ, VAN VUNAKIS H, editors. Methods in enzymology. Academic Press, 1984;108:88-102.
30. 30. FERNVIK E, LUNDAHL J, HALLDÉN G. The impact of eotaxin-and IL-5-induced adhesion and transmigration on eosinophil activity markers. Inflammation 1999(in press).
31. 31. LUNDAHL J, MOSHFEGH A, GRÖNNEBERG R, HALLDÉN G. Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL-5, but not fMLP-prestimulated human peripheral blood eosinophils. Inflammation 1998;22:123-135.
32. 32. HALLDÉN G, ANDERSSON U, HED J, et al. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J Immunol Methods 1989;124:103-109.
33. 33. HALLDÉN G, HED J. The FOG method a new approach to detecting activated eosinophils. ACI News 1993;139-143.
34. 34. LUTTMANN W, KNOECHEL B, FOERSTER M, MATTHYS H, VIRCHOW JC Jr, KROEGEL C. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J Immunol 1996;157:1678-1683.
35. 35. OKUBO Y, HOSSAIN M, KAI R, et al. Adhesion molecules on eosinophils in acute eosinophilic pneumonia. Am J Respir Crit Care Med 1995;151:1259-1262.
36. 36. LUTTMANN W, MATTHIESEN T, MATTHYS H, VIRCHOW J Jr. Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor on eosinophil activation in vitro. Am J Respir Cell Mol Biol 1999;20:474-480.
37. 37. ISHIHARA C, OCHIAI K, TAKASHAHI M, et al. Human peripheral eosinophils express functional interferon-gamma receptors (IFN-γR). Clin Exp Immunol 1997;110:524-529.
38. 38. FUKUDA T, MAKINO S. Heterogeneity and activation in eosinophils: biological and clinical aspects. In: MAKINO S, FUKUDA T, editors. Eosinophils, biological and clinical aspects. Boca Raton, FL: CRC Press, 1992:155-170.
39. 39. SIEFF CA, NIEMEYER CM, FALLER DV. Human colony-stimulating factors and stromal cell function. Soc Gen Physiol Ser 1988;43:47-55.
40. 40. FERNVIK E, HALLDÉN G, HED J, LUNDAHL J. Intracellular and surface distribution of CD9 in human eosinophils. APMIS 1995;103:699-706.
41. 41. RINDER HM, BONAN JL, RINDER CS, AULT KA, SMITH BR. Activated and unactivated platelets' adhesion to monocytes and neutrophils. Blood 1991;34:1760-1769.
42. 42. WALSH GM, WILLIAMSON ML, SYMON FA, WILLARS GB, WARDLAW AJ. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood 1996;87:2815-2821.